Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.
Wrench Group offers home repair, replacement and maintenance services specializing in heating and ventilation.
Finastra provides the broadest portfolio of financial services software.
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Klaviyo is an automation and email platform designed to help grow businesses.
Clinical stage biotechnology company developing restorative treatments for people affected by neuropsychiatric & neuroimmunologic disorders
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.
Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
Context Therapeutics is a clinical-stage biopharmaceutical company.
Allica Bank is a fintech company that delivers digital banking services for small and medium-sized businesses.
Coherent is a software-as-a-service company for insurance companies.
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
Securiti is the pioneer of the DataAI Command Center, a centralized platform that enables the safe use of data and GenAI.
Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.
Deep Fission is transforming the energy landscape by installing modular nuclear power reactors a mile deep.
Blue Owl has invested in 69 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Blue Owl's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Medical, Biopharma. The firm invests across 43 different industry categories.
Among tracked funding rounds, Finastra received $5.3B in a Debt Financing round. Blue Owl's total known invested capital is $33.6B.
Blue Owl's average investment size is $685.7M across its portfolio of 69 companies.
Recent Blue Owl portfolio additions include Pyxis Oncology, Wrench Group, Finastra, MapLight Therapeutics, Klaviyo. These companies were founded in 2020 or later.